[ATRA] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[ATRA] Atara Biotherapeutics, Inc.
Announcement Date
09-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- 17.19%
YoY- -59.88%
Quarter Report
ATRA's Result
ATRA's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 7,314 3,552 0 0 0 0 0 -
PBT -88,105 -78,335 -73,509 -66,257 -41,443 -25,652 -16,558 32.11%
Tax -115 -373 0 0 0 2 3 -
NP -881,050 -783,350 -735,090 -662,570 -414,430 -256,540 -165,610 32.10%
Tax Rate - - - - - - - -
Total Cost 888,364 786,902 735,090 662,570 414,430 256,540 165,610 32.29%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -1,204.61 -2,205.38 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -21.87 -21.41 -30.02 -35.91 -26.17 -22.07 -14.51 7.07%
EPS Diluted -21.87 -21.41 -30.02 -35.91 -26.17 -22.07 -14.51 7.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.